EDGE
Get a demo
Log In

Evaxion Biotech

Recent Updates

Funding
Feb 1, 2024
Evaxion Biotech to raise USD 15 million in IPO to fuel clinical development
AI Drug Discovery
Mar 23, 2023
Evaxio launches proprietary AI platform technology, ObsERV
AI Drug Discovery
Funding
Jun 7, 2022
Evaxion Biotech secures USD 40 million from Lincoln Park Capital
AI Drug Discovery
Earnings/results
Nov 9, 2021
Evaxion Biotech beats analyst estimates in Q3 2021
AI Drug Discovery
Funding
Nov 5, 2021
Evaxion Biotech to raise USD 24 million in follow-on public offering
AI Drug Discovery
Partnerships
Oct 25, 2021
Evaxion Biotech teams up with Merck’s Keytruda
AI Drug Discovery

Company Brief


HQ location:
Bredgade 34E Copenhagen DNK
Founded year:
2008
Employees:
51-100
Total Funding:
USD 92.0 million
Last Funding
USD 15.0 million, Feb 2024

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.